Daubresse, Matthew
Alexander, G. Caleb
Crews, Deidra C.
Segev, Dorry L.
Lentine, Krista L.
McAdams-DeMarco, Mara A. https://orcid.org/0000-0003-3013-925X
Funding for this research was provided by:
NIDDK (R01DK114074, R01DK120518, R01DK120518)
National Institute on Aging (R01AG055781)
National Center on Minority Health and Health Disparities (U01MD010550)
National Heart, Lung, and Blood Institute (K24HL148181)
Article History
Received: 14 May 2020
Accepted: 9 February 2021
First Online: 23 February 2021
Change Date: 13 April 2021
Change Type: Update
Change Details: We have corrected affiliation#6 for consistent order.
Change Date: 15 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12882-021-02332-y
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Alexander is past Chair of FDA’s Peripheral and Central Nervous System Advisory Committee; has served as a paid advisor to IQVIA; is a co-founding Principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation; and is a member of OptumRx’s National P&T Committee. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies.